We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Reverses Priority In Claritin Battle

Law360 (February 6, 2006, 12:00 AM EST) -- In a protracted patent interference case, a pharmaceutical company hoping to trump its rival’s patent for making Claritin’s active ingredient has lost once again at the U.S. Court of Appeals for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.